Guangzhou Kingmed Diagnostics Group Co., Ltd.
Shanghai Stock Exchange:603882.SS
Sector
Location
Market Cap
USD 1.96 B
Share Price
USD 4.22
Avg Daily Volume
7,982,126
Change (1 day)
-1.25%
Change (1 year)
1.90%
Change (YTD)
11.82%
Guangzhou Kingmed Diagnostics Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 124.13 M
Guangzhou Kingmed Diagnostics Group Co., Ltd. Operating Cash Flow is USD 124.13 M for the year ending December 31, 2024, a -28.40% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Guangzhou Kingmed Diagnostics Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 173.36 M, a -38.58% change year over year.
-
Guangzhou Kingmed Diagnostics Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 282.26 M, a -14.10% change year over year.
-
Guangzhou Kingmed Diagnostics Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 328.60 M, a 40.83% change year over year.
-
Guangzhou Kingmed Diagnostics Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 233.34 M, a 145.68% change year over year.
StockViz
Competitors
Fresenius SE & Co. KGaA
USD 51.55
FRE.DE
+0.67
1.32%
Labcorp Holdings Inc.
USD 269.31
LH
+1.64
0.61%
Sino Biopharmaceutical Limited
USD 0.98
1177.HK
+0.03
2.68%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.83
603392.SS
-0.04
-0.55%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.04
300832.SZ
+0.06
0.71%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.31
0874.HK
+0.02
0.73%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.05
600079.SS
+0.03
1.02%
AddLife AB (publ)
USD 17.08
ALIF-B.ST
+0.06
0.38%
Eli Lilly and Company
USD 639.43
LLY
+4.21
0.66%
AbbVie Inc.
USD 198.64
ABBV
-0.06
-0.03%
Roche Holding AG
USD 320.12
RO.SW
+2.62
0.83%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 119.03
NOVN.SW
+1.05
0.89%
Novo Nordisk A/S
USD 50.00
NOVO-B.CO
-0.09
-0.18%
Merck & Co., Inc.
USD 80.30
MRK
+0.27
0.34%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Fresenius SE & Co. KGaA
USD 51.55
FRE.DE
+0.67
1.32%
Labcorp Holdings Inc.
USD 269.31
LH
+1.64
0.61%
Sino Biopharmaceutical Limited
USD 0.98
1177.HK
+0.03
2.68%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.83
603392.SS
-0.04
-0.55%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.04
300832.SZ
+0.06
0.71%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.31
0874.HK
+0.02
0.73%
Humanwell Healthcare (Group) Co.,Ltd.
USD 3.05
600079.SS
+0.03
1.02%
AddLife AB (publ)
USD 17.08
ALIF-B.ST
+0.06
0.38%
Eli Lilly and Company
USD 639.43
LLY
+4.21
0.66%
AbbVie Inc.
USD 198.64
ABBV
-0.06
-0.03%
Roche Holding AG
USD 320.12
RO.SW
+2.62
0.83%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 119.03
NOVN.SW
+1.05
0.89%
Novo Nordisk A/S
USD 50.00
NOVO-B.CO
-0.09
-0.18%
Merck & Co., Inc.
USD 80.30
MRK
+0.27
0.34%